Mobile application for epilepsy education in children
Unicentre Parallel Open Randomized Trial to Evaluate the Efficacy of a Mobile Epilepsy Education Application Developed For The Parents/Caregivers of Children With Epilepsy in Canada
This study is testing a new mobile app to see if it can help parents and caregivers of children with epilepsy learn more about the condition and feel less anxious.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Sex | All |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 2 sites (Montréal, Quebec and 1 other locations) |
| Trial ID | NCT06402526 on ClinicalTrials.gov |
What this trial studies
This study evaluates the efficacy of the Mobile Epilepsy Education Package (MEEP), an application designed to educate parents and caregivers of children diagnosed with epilepsy. The trial involves a two-group, single-center, randomized controlled intervention where participants will use either the MEEP or receive standard care. The primary objective is to assess whether the MEEP increases knowledge about epilepsy, while secondary objectives include reducing anxiety and improving treatment adherence through app features. The study will be conducted at the Montreal Children's Hospital and the Research Institute of the McGill University Health Centre.
Who should consider this trial
Good fit: Ideal candidates are parents or caregivers of children aged 1-17 who have been diagnosed with epilepsy for at least two months and are comfortable using a smartphone in English or French.
Not a fit: Patients who are unable to provide informed consent or do not have access to a smartphone may not benefit from this study.
Why it matters
Potential benefit: If successful, this application could significantly enhance the knowledge and reduce anxiety of families dealing with childhood epilepsy.
How similar studies have performed: Previous studies have shown success with similar educational interventions, indicating potential for positive outcomes in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parents/caregivers whose children are between 1-17 years old; * Parents/caregivers whose child was diagnosed with epilepsy at least 2 months ago; * At least one primary caregiver is comfortable interacting in English or French; and * At least one primary caregiver owns and uses a smartphone on a daily basis. Exclusion Criteria: - Inability to provide informed consent for any reason.
Where this trial is running
Montréal, Quebec and 1 other locations
- Montreal Children's Hospital — Montréal, Quebec, Canada (Recruiting)
- Research Institute of the McGill University Health Centre — Montréal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Kenneth Alexis Myers, MD PhD FRCPC — RI-MUHC, Montreal Children's Hospital, McGill University
- Study coordinator: Kenneth Alexis Myers, MD PhD FRCPC
- Email: kenneth.myers@mcgill.ca
- Phone: 514-934-1934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.